-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, H76YD4sd3D7RR8fuiVU5Zd7GI/+famvEJ6x2RmAUBxt/Bkejn8fiAe7/5mmICsoQ LNbX3geFon7aJE0uftwIOw== 0000891618-07-000214.txt : 20070402 0000891618-07-000214.hdr.sgml : 20070402 20070402172942 ACCESSION NUMBER: 0000891618-07-000214 CONFORMED SUBMISSION TYPE: 15-12G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20070402 DATE AS OF CHANGE: 20070402 EFFECTIVENESS DATE: 20070402 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ADEZA BIOMEDICAL CORP CENTRAL INDEX KEY: 0000902482 STANDARD INDUSTRIAL CLASSIFICATION: INSTRUMENTS FOR MEAS & TESTING OF ELECTRICITY & ELEC SIGNALS [3825] IRS NUMBER: 770054952 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 15-12G SEC ACT: 1934 Act SEC FILE NUMBER: 000-20703 FILM NUMBER: 07740730 BUSINESS ADDRESS: STREET 1: 1240 ELKO DR CITY: SUNNYVALE STATE: CA ZIP: 94089 15-12G 1 f28871e15v12g.htm FORM 15-12G e15v12g
 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES
EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934.
Commission File Number 000-20703
Cytyc Prenatal Products Corp.
f/k/a
Adeza Biomedical Corporation
 
(Exact name of registrant as specified in its charter)
1240 Elko Drive
Sunnyvale, California 94089
(408) 745-0975
 
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)
Common Stock, par value $0.001 per share
 
(Title of each class of securities covered by this Form)
None
 
(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)
     Please place an X in the box(es) to designate the appropriate rule provisions(s) relied upon to terminate or suspend the duty to file reports:
             
Rule 12g-4(a)(1)(i)
  þ   Rule 12h-3(b)(1)(i)   þ
Rule 12g-4(a)(1)(ii)
  ¨   Rule 12h-3(b)(1)(ii)   ¨
Rule 12g-4(a)(2)(i)
  ¨   Rule 12h-3(b)(2)(i)   ¨
Rule 12g-4(a)(2)(ii)
  ¨   12h-3(b)(2)(ii)   ¨
 
      Rule 15d-6   ¨
Approximate number of holders of record as of the certification or notice date:     One
Pursuant to the requirements of the Securities Exchange Act of 1934, Cytyc Prenatal Products Corp. f/k/a Adeza Biomedical Corporation has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.
         
     
Date: April 2, 2007  By:   /s/ Patrick J. Sullivan    
    Name:   Patrick J. Sullivan   
    Title:   President   
 
Instruction: This form is required by Rules 12g-4, 12h-3 and 15d-6 of the General Rules and Regulations under the Securities Exchange Act of 1934. The registrant shall file with the Commission three copies of Form 15, one of which shall be manually signed. It may be signed by an officer of the registrant, by counsel or by any other duly authorized person. The name and title of the person signing the form shall be typed or printed under the signature.

 -----END PRIVACY-ENHANCED MESSAGE-----